Bumrungrad International Hospital, led by Assoc. Prof. Taveesin Tanprayoon, MD, Chief Medical Officer, together with Pat Ongcharit, MD, Cardiothoracic Surgeon; Pol. Capt. Sakolwat Montrivade, MD, Cardiologist and Interventional Cardiologist; Piyachat Pipatpongsopon, MD, Advanced Heart Failure and Transplant Cardiologist and General Cardiologist; and Rujira Songprakhon, Division Director, Clinical Service Line–OPD 1, participated in a media group interview titled “Bumrungrad’s Complete Heart Failure Care Pathway: A Second Chance at Life,” held on August 4, 2026, at Bumrungrad International Hospital.
Heart failure is the final stage of many forms of heart disease, particularly among critically ill patients, where every minute counts. Rapid diagnosis, early referral, and timely access to a multidisciplinary team of specialists are essential to improving survival and ensuring that patients receive advanced therapies when they are most effective.
Bumrungrad International Hospital has more than 20 years of successful experience in heart transplantation. The hospital is officially authorized by the Thai Red Cross Society as a Heart Transplant Center and is accredited with the JCI Heart Failure Certification from the United States. Its outstanding clinical outcomes include a 0% 30-day post-operative mortality rate and an approximately 85-90% post-transplant survival rate. These achievements reflect Bumrungrad’s expertise in delivering Complete Heart Failure Care, providing comprehensive management across every stage of the patient journey—from medical therapy and advanced mechanical circulatory support technologies, including ECMO and pVAD (Impella), known collectively as ECPELLA, to bridge patients to heart transplantation, through to post-treatment rehabilitation. Guided by a family-centered Care approach and supported by a seamlessly integrated multidisciplinary team, Bumrungrad is committed to giving patients and their families the opportunity for a new beginning.
Last modify: August 10, 2026